← Leaderboards
Christian Brendel
Dana-Farber Cancer Inst
$1,241,366
Attributed
$2,482,731
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $890K · FY2021–25$1M$750K$500K$250K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,482,731 · 2
By mechanism
R01$2,482,731 · 2
Top collaborators
- Daniel Evan Bauer2 shared
- David A Williams2 shared
Most similar at Dana-Farber Cancer Inst
Same institution · by research overlap
- Anupama Narla$773,118
- Alyssa Kennedy$742,865
- Robert Coleman Lindsley$5,306,772
- Piotr Sicinski$42,703,610
- Alessandra Biffi$1,098,714
Others in their field
Other Emerging Leaders on “Mediating”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Yunda Huang · Fred Hutchinson Cancer Center$73,602,469
- James Dale Berry · Brigham And Women'S Hospital$25,538,716
- Ionut Bebu · George Washington University$18,816,779
- Barbara Halina Braffett · George Washington University$18,816,779
- Gary Fanger · Rise Therapeutics, Llc$17,847,765
Research focus
MediatingIn VitroHematopoietic Stem CellsLentivirus VectorToxic EffectCellular TransductionEngineeringGene TransferInnovationIn VivoModalityStem Cell Gene TherapyTransplantationMedicalComplexDoseEngraftmentGene TherapyCellsBiodistributionBackBone Marrow TransplantationAnimal ModelBone Marrow Failure
Grant awards (4)
In vivo hematopoietic stem cell genetic modification by viral particles$874,907
R01 · FY2025 · HL
In vivo hematopoietic stem cell genetic modification by viral particles$889,998
R01 · FY2024 · HL
Hematopoietic stem cell gene therapy for infantile neuronal ceroid lipofuscinosis$358,913
R01 · FY2022 · HD
Hematopoietic stem cell gene therapy for infantile neuronal ceroid lipofuscinosis$358,913
R01 · FY2021 · HD